U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H30N6O3
Molecular Weight 474.5548
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MACIMORELIN

SMILES

CC(C)(N)C(=O)N[C@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC3=CNC4=C3C=CC=C4)NC=O

InChI

InChIKey=UJVDJAPJQWZRFR-DHIUTWEWSA-N
InChI=1S/C26H30N6O3/c1-26(2,27)25(35)31-22(11-16-13-28-20-9-5-3-7-18(16)20)24(34)32-23(30-15-33)12-17-14-29-21-10-6-4-8-19(17)21/h3-10,13-15,22-23,28-29H,11-12,27H2,1-2H3,(H,30,33)(H,31,35)(H,32,34)/t22-,23-/m1/s1

HIDE SMILES / InChI

Molecular Formula C26H30N6O3
Molecular Weight 474.5548
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 17:21:23 UTC 2023
Edited
by admin
on Fri Dec 15 17:21:23 UTC 2023
Record UNII
8680B21W73
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MACIMORELIN
DASH   INN   USAN   WHO-DD  
INN   USAN  
Official Name English
EP-1572
Code English
MACIMORELIN [MI]
Common Name English
D-87575
Code English
JMV-1843
Code English
ARD-07
Code English
ARD07
Code English
N(SUP 2)-(2-AMINO-2-METHYLPROPANOYL-N1-((1R)-1-FORMAMIDO-2-(1H-INDOL-3-YL)ETHYL)-D-TRYPTOPHANAMIDE
Common Name English
Macimorelin [WHO-DD]
Common Name English
MACIMORELIN [USAN]
Common Name English
AEZS-130
Code English
EP-01572
Code English
macimorelin [INN]
Common Name English
EP1572
Code English
Classification Tree Code System Code
WHO-ATC V04CD06
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
NCI_THESAURUS C76358
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
NDF-RT N0000193785
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
Code System Code Type Description
PUBCHEM
9804938
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
SMS_ID
100000175809
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
DAILYMED
8680B21W73
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
NCI_THESAURUS
C95123
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
RXCUI
1999420
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
FDA UNII
8680B21W73
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
DRUG BANK
DB13074
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
WIKIPEDIA
MACIMORELIN
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
USAN
AB-25
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
CAS
381231-18-1
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
DRUG CENTRAL
5271
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
EPA CompTox
DTXSID601045766
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
MERCK INDEX
m12057
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
INN
9073
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
ChEMBL
CHEMBL278623
Created by admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
METABOLIC ENZYME -> SUBSTRATE
TARGET -> AGONIST
test for adult GH deficiency:
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC ORAL ADMINISTRATION

Tmax PHARMACOKINETIC ORAL ADMINISTRATION